8:15 a.m.

Recent Advances in Blood/Marrow Transplantation (BMT), Robert Collins, MD

Over the years BMT has been used with increasing frequency to treat numerous malignant and nonmalignant diseases. This session will provide an overview of recent approaches in BMT aimed to reduce toxicity, graft-vs.-host disease (GVHD), and relapse; increase donor availability; and bring precision to patient selection.

Learning Objectives:

1. Define reduced-intensity conditioning (RIC) for allogeneic stem cell transplant.
2. Discuss recent trends in the use of alternative donors.
3. Review new approaches to GVHD prophylaxis and disease relapse.
4. Describe the use of new clinical tools that can assist in improving patient selection. 

8:45 a.m.

Management of Long-Term Survivors of BMT, Madhuri Vusirikala, MD

The long-term care of survivors of blood/marrow transplantation is complex, requiring coordinated care across many disciplines. This session will discuss late complications post blood/marrow transplantation, prevention and management of complications, screening, and follow-up guidelines for long-term survivors of both autologous and allogeneic stem cell transplant.
 
Learning Objectives:

1. List the delayed complications associated with post-stem-cell transplantation.
2. State the risk factors related to transplant complications.
3. Describe the recommendations for screening patients posttransplant.
4. Discuss the role of immunizations in post-stem-cell transplantation.
5. Outline the follow-up guidelines for long-term survivors of both autologous and allogeneic stem cell transplantation.

9:15 a.m.

Integrating Transplantation with Novel Therapies in Myeloma, Larry D. Anderson, MD, PhD

New therapies for multiple myeloma have dramatically improved life expectancy for patients with this disease. This session will provide an overview of myeloma therapy with an emphasis on the role of autologous stem cell transplant (SCT) and sequencing with novel therapies. 

Learning Objectives:

1. Describe the role of SCT for myeloma in the current era of novel therapies.

10:00 a.m.

Management of Complex Psychosocial Issues in Blood/Marrow Transplantation Patients, Prapti Patel, MD

The psychosocial well-being and quality of life for transplant patients are key long-term goals for the transplant team, along with the prevention of psychosocial barriers and noncompliance-related behaviors. This session will review specific psychosocial issues that transplant patients face and management strategies to help patients overcome them.

Learning Objectives:

1. Describe the pre- and posttransplant process from a psychosocial standpoint.
2. Identify psychosocial barriers to stem cell transplantation and their effect on transplant outcomes.
3. Describe programs that are designed to assist patients as they move through the transplant process.

10:45 a.m.

Palliative Care, Tamara McGregor, MD

1:15 p.m.

Human Leukocyte Antigen (HLA): Why Is It Important? Chantale Lacelle, PhD, D(ABHI)

HLA matching is an important factor for a successful transplant. This session will provide an overview of the HLA system, explain key terms such as calculated panel reactive antibody (cPRA), donor specific antibody (DSA) and unacceptable antigens. It will also briefly explain how the cPRA is used in organ allocation and how HLA data is used in paired exchanged programs. 

Learning Objectives:

1. Appreciate the polymorphic nature of the HLA system.
2. Recognize the difference between sensitized and nonsensitized patients.
3. Define the concepts of cPRA, DSA and unacceptable antigens.
4. Describe how cPRA is used in the new United Network for Organ Sharing (UNOS) kidney allocation system.
5. Discuss how HLA data is used in paired exchanged programs.

1:45 p.m.

ABC of Transplantation in the Setting of New UNOS Allocation System, Miguel Vazquez, MD, and Bekir Tanriover, MD, MPH

The goal of the UNOS organ allocation system is to achieve a balance in organ allocation. This session will review outcomes of renal transplantation over the last decade, implications of the new UNOS deceased-donor kidney transplant allocation system and emerging trends to improve organ shortage.

Learning Objectives:

1. State kidney transplant outcomes.
2. Discuss the pros and cons of the new UNOS allocation system.
3. Describe the management of the organ shortage and its future direction.

2:45 p.m.

Living Donor Kidney Transplant, Christine Hwang, MD

Learning Objectives:

1. Define the eligibility criteria to become a living donor.
2. Identify the benefits of living kidney donation for the recipient.
3. State the risks of living kidney donation for the donor.

3:15 p.m.

Heart/Kidney Transplant Patient, Dana McCullough

Learning Objectives:

1. Describe each step of the transplant process from a patients perspective including the transplant evaluation, hospital and posttransplant experience.
2. Identify helpful questions for patients to ask during the transplant evaluation.
3. List helpful resources for patients undergoing organ transplantation.